The ability of lipid-free apoA-I and apoA-II to increase Pdx1 gene expression raises the possibility that these apolipoproteins may conserve β-cell function and reduce the adverse effects of activated T-cells in T1D [73,74]. This evidence concerns the gene APOA1 and type 1 diabetes mellitus.